IPO Growth AOTI recently completed an IPO on London's AIM in mid 2024, raising substantial funds. This indicates increased public visibility, scale potential, and a growing need for enterprise-grade operational and financial systems to support expansion—presenting opportunities for ERP, CRM, treasury, and analytics solutions.

Wound Care Leader Positioned as a global leader in multimodality topical wound oxygen therapy with a focus on chronic conditions, creating demand for clinical efficiency tools, remote patient monitoring, and data integration to improve outcomes and reporting across care pathways.

Healthcare Partnerships Strategic collaborations with entities like the American Dental Association and participation in European wound care events show receptiveness to ecosystem partnerships, suggesting opportunities for channel partnerships, training programs, and co-marketing initiatives.

Tech Stack Maturity Adopted enterprise tools including Anaplan, Hyperion, Salesforce, and Microsoft 365, signaling readiness for advanced data analytics, financial planning, CRM-driven sales motions, and scalable collaboration—targets for optimization and integration projects.

Growth Financing Significant fundraising activity and growth-focused funding from prior years imply a trajectory toward scale manufacturing, export growth, and expanded sales teams, offering upsell opportunities for manufacturing optimization, ERP, supply chain readiness, and field service enhancements.